Continental Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Consumer Portfolio Services
CPSS
|
+$3.1M |
| 2 |
HOLX
Hologic
HOLX
|
+$2.02M |
| 3 |
Medtronic
MDT
|
+$1.72M |
| 4 |
KCG
KCG Holdings, Inc.
KCG
|
+$1.42M |
| 5 |
CERN
Cerner Corp
CERN
|
+$1.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axos Financial
AX
|
+$2.17M |
| 2 |
FNBC
First NBC Bank Holding Company
FNBC
|
+$1.25M |
| 3 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$1.19M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$980K |
| 5 |
CVD
COVANCE INC.
CVD
|
+$967K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.04% |
| 2 | Healthcare | 15.29% |
| 3 | Consumer Discretionary | 2.78% |
| 4 | Real Estate | 2.01% |
| 5 | Technology | 0.8% |
Similar funds
Continental Advisors's Q3 2014 Portfolio in Review
As of Q3 2014, Continental Advisors held 171 positions worth $439M, up 2.3% from $429M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Continental Advisors deployed $16.8M of net new capital in Q3 2014, opening 39 new positions and adding to 35 existing holdings. Its largest new stake was Cerner Corp: 25,000 shares worth $1.49M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $980K trimmed.
- Continental Advisors's largest Q3 2014 buy was Cerner Corp: 25,000 shares worth $1.49M.
- Continental Advisors added most to Consumer Portfolio Services in Q3 2014, an estimated $3.1M increase.
- Continental Advisors's biggest Q3 2014 reduction was Teva Pharmaceuticals, cutting an estimated $980K.
- Continental Advisors fully exited Axos Financial in Q3 2014, selling an estimated $2.17M.
- Continental Advisors's ten largest holdings make up 36% of its $439M portfolio in Q3 2014.
- Continental Advisors opened 39 new positions and closed 24 in Q3 2014.
- Continental Advisors's portfolio value rose 2.3% quarter-over-quarter to $439M.
Based on Continental Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.